Amanda Matthews, Senior Director, Regulatory
CMC for Combination Products & Medical Devices at Pfizer, provides an
exclusive insight into the challenges
of working between medical device and pharmaceutical companies, following the transition from development to
commercial.
Ahead of
this year’s Drug-Device Combination Products conference, Amanda Matthews answers
the following questions:
- What are the biggest challenges
you experience when collaborating between medical device and pharma companies?
- What works well for you when
collaborating across the whole lifecycle management?
- Is it common for pharma and medical
device companies to miscommunicate with the language they use? Are you
able to clarify what some of the fundamental terms are?
- What would be your top tips then
for anyone successfully trying to work together?
Amanda Matthews
will also participate in a round table and panel discussion at this year’s
conference to discuss the impact of the EU MDR and how you can improve the
collaboration to optimize processes. More information on the session can be
found here.